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 One of the most frequently prescribed drugs in geriatric patients is a 
benzodiazepine, especially a short-acting such as alprazolam. Unfortunately, 
alprazolam is oftenly used inappropriately because this drug has a short 
acting effect. Geriatric patients are more sensitive to this drug that can lead to 
the dependence. However, there is still lack of data on the use of this drug in 
geriatric patients. The aim of this study was to determine the prevalence of 
the use of alprazolam. A drug utilization study has been done for 2 months 
through analysis of patient’s medical records in the internal medicine ward at 
RSMH Palembang from June 1st, 2012 to May 31st, 2013. There were 25 out 
of 1634 patients receiving alprazolam, but only 23 patients whose data were 
obtained from the available medical records. Prevalence of alprazolam use 
was 1.408%. Based on gender, the prevalence was 1.798% in female and 
1.09% in male patients. Proportion by age group was 91.3%, 8.7% and 0% in 
age group 60-74 years, 75-90 years and over 90 years, respectively. Based on 
the job, the population study comprised of the housewive (52.1%), 
unemployment (39.1%), and entrepreneur and farmer (4.3% together). The 
indication of usage was atheroscerotic heart disease, diarrhoea and 
gastroenteritis of presumed infectious origin, unspecified gastritis, and 
thyrotoxic heart disease. In other words, it could be said that the usage of 
alprazolam was inappropriate. 
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1. INTRODUCTION  
Aging is defined as a process that transforms an adult into a weak person by reducing in most of the 
physiological system backup and increased susceptibility to various diseases and death [1]. Change in 
response to some drug occurs with increase of age in many people. Pharmacological changes in geriatric 
patients such as changes in the mechanism of absorption, distribution, metabolism, and elimination of drugs. 
Patterns of drug use are also change due to the increasing incidence of disease according to age and the 
tendency for doctors to prescribe excessive drugs for patients in nursing homes [2]. One of drug type that is 
often used in the elderly is a group benzodiazepine [3].  
Data from The Drug Abuse Warning Network (DAWN) found that opioids and benzodiazepines are 
the two drugs that most frequently reported in cases of drug abuse [4]. Benzodiazepines are often misused as 
a result of their sedation effect mainly in the short-acting benzodiazepine such as alprazolam. Alprazolam is a 
medication used for the short term treatment of anxiety and panic disorder. This drug is not recommended as 
first-line because of the risk of dependence and the potentiation for misuse [5]. Beside that, alprazolam has a 
rapid onset and this medication is classified as a high potency drug [6]. 
                ISSN: 2252-8806 
IJPHS Vol. 5, No. 2, June 2016:  193 – 200 
194
Alprazolam, clonazepam, diazepam, and lorazepam are four types of benzodiazepines were recorded 
as 200 drugs that are most frequently used in USA [7],[8]. Meanwhile, the National Forensic Laboratory 
System (NFLIS) said that there was an increase in the use of alprazolam by 75% from 2001 until 2005 [9].  
The short acting effect, high potential and short half-life of alprazolam allows users to continuously 
use this drug even outside of the treatment due to the occurrence of dependence. Beside that, alprazolam is 
often prescribed inappropriately and outside of the indications. These drugs included in the Beer’s criteria 
2012 of Pottentially Inappropriate Prescriptions for Elderly because there is high incidence of improper 
administration of alprazolam. The use of alprazolam increased in elderly patients related to the problem that 
often encountered in elderly such as sleep disturbance and anxiety. Data from epidemiological and 
experimental studies mentioned that the elderlys are more sensitive to the central nervous system effects of 
benzodiazepine [10]. This statement indicates that the benefit of BZD use in the elderly is still unclear. 
Cumming et al., (2003) [11] concluding that benzodiazepine prescription should be limited in geriatric 
patients and the elderly who have been taking this drug should start trying to reduce the usage under hospital 
supervision.  
Based on the data above, the study aim was to determine the prevalence of alprazolam use to 
geriatric patients at the General Hospital Mohammad Hoesin Palembang on June 1st, 2012- May 31st, 2013 
period to prove the truth of the reality because there is tendency of alprazolam inappropriate prescription 
accoring to the Beers criteria in 2012 and the dependence effets of the use of these drugs in the long term 
treatment. 
 
 
2. RESEARCH METHOD 
The study protocol has approved by ethical committee of medical faculty of Sriwijaya University. 
This research was conducted at the General Hospital of Muhammad Hoesin Palembang, South Sumatera, 
Indonesia for 2 months through analysis of medical records of patients aged > 60 years as the population who 
are hospitalized in internal medicine wards A to F on 1 June 2012 – 31 May 2013 period. Patient medical 
records which have unclear information or illegible are excluded from this research.  
There was 1634 geriatric inpatient which found through computerized system of RSMH inpatient 
medical record. Then, through pharmacy computerized system we search for the patient who received 
alprazolam during treatment.  
We enter the patient's medical record number to computer and we get patient pharmacy data during 
hospitalization. Through these searches, we found 25 geriatric patients who receive alprazolam. Then, we 
look for the patient’s medical records of patients who had been identified in the medical record computerized 
system. However, after a search through medical records, two data are not found so there are only 23 data 
which we use in this research as a subject. 
Medical records are then studied to match the computerized search results with the original data, 
then we recorded all patient data that are needed,  particularly variable in this study that are age, gender, 
occupation, indications, and side effects of treatment. Then, the data obtained are included in the SPSS 
system to facilitate the reading of data. The results in this study are presented in the form of tables and graphs 
with the narrative. 
 
 
3. RESULTS AND DISCUSSION 
From 1634 geriatric patients, the majority of hospitalized patients were in the age group of 60-74 
years (1365/83.5%). The total of 911 patients were male (55.7%) and the remaining 723 patients are female 
(44.2%). Population’s sociodemographic data can be seen in Table 1. 
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From the 1634 patients, there were 23 patients who received alprazolam, so that the prevalence of 
use of these drugs was 1.408% (23/1634) (Table 2). The results of this study indicate that most of  the 
alprazolam use was in the age group 60-74 years (21/91, 3%), followed by age group 75-90 (2/8.7%), while 
at the very old age group (> 90 years) there is no use of alprazolam. 
 
 
Table 1. Population’s Sex and Age Distribution 
 Total (n=1634) Percentage (n=100%) 
Age 
60-74 year 
75-90 year 
>90 year 
Sex 
Male 
Female 
 
1365 
259 
10 
 
911 
723 
 
83 
15.9 
0.6 
 
55.8 
44.2 
 
 
The total of 13 patients was women (56.5%) and the remaining 13 were men (43.5%). Based on 
these data we can determine that the prevalence of use in women is 1.798% (13/723) and men are 1.09% 
(10/901). This suggests that more woman recieve alprazolam than man.  
For job variable, alprazolam most widely administered to women who work as housewives (52.1%; 
12), followed by patients who are not working due to old age (39.1%;9), and last, the self-employed and 
farmer 4.3%, respectively (1 patient). The sociodemographic data can be seen in Table 3. 
Alprazolam was given to hospitalized patients in internal medicine wards for various indications 
according to ICD 10 criteria. From these results they appear that the diagnosis in patients spread without any 
dominant disease. Alprazolam was administered in patients with an indication of atheroscerotic heart disease, 
diarrhoea and gastroenteritis of presumed infectious origin, dyspepsia, unspecified gastritis, and thyrotoxic 
heart disease (THD) / thyrotoxicosis / unsspecified, two cases respectively (8.7%). While the rest which are 
acute myocardial infarction, anaemia, asthma, chronic obstructive pulmonary disease, chronic renal failure, 
congestive heart failure (CHF), eseential (primary) hypertension, gastric ulcer, hypertensive heart disease 
without (congestive) heart failure, non-insulin dependent diabetes mellitus, other diseases of  
digestive system (melaena), other gastritis, and volume depletion is only a single case (4.3%). Data indicative 
of alprazolam administration can be seen in Table 4. 
Table 5 shows that the entire uses of alprazolam were improper (100%) because there were a lack of 
records or a through assessment in anxiety disorders and panic attacks in the patient's medical record, while 
alprazolam only indicated for panic attacks and generelized anxiety disorder. These data indicate that there is 
Potentially Inappropriate Prescriptions (PIP) in geriatric patients. 
Alprazolam is given outside of the main indications given above and this drug just use based on 
another effect of the nature of this drug work which basically does not fit in the context of rational treatment. 
Meanwhile, when viewed from the primary diagnosis, the appropriateness of the prevalence can not be 
assessed directly, because all patients were treated over the main indications and alprazolam mostly just a 
symptomatic drug against the patient's complaint. 
 
 
Table 2. Prevalence Use of Alprazolam 
 
 
 
 
 
 
Side effects of treatment can not be found in the medical records because the side effects of 
treatment are not written by doctors and nurses who treated patients. This is due to the large number of 
hospitalized patients in and out every day, so that the medical team difficult to follow up all the patients. 
 
3.1. Discussion 
From the Table 2 above, known that the prevalence of the use of alprazolam in geriatric patients are 
1.408%, or 23 of the 1634 patients who were hospitalized. This figure shows that the use of alprazolam is 
low. However, use of these drugs should be also reviewed not only by its numbers but also from the 
indication or the reason why doctor choose this drug. Reconnexion (2010) mentions that the elderly aged 
over 65 years  get prescription of benzodiazepines as much as 11%,  more than the adult population which 
 n Receive n Not Receive % Receive % Not Receive 
>60 year 
Male 
Female 
23 
10 
13 
1611 
901 
710 
1.408 
1.09 
1.798 
98.592 
98.902 
98.202 
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only 5% [12]. The study result of Nakao et al. (2009) [13] also found more elderly patients received this drug 
class than young adults. 
 
 
Table 3. Socio Demographic Data of Alprazolam User  
 Total (n= 23) Percentage (n=100%) 
Age 
60-74 year 
75-90 year 
>90 year 
Sex 
Male  
Female 
Jobs  
Not Work 
Housewives 
Farmer 
Entrepreneur 
 
21 
2 
0 
 
10 
13 
 
9 
12 
1 
1 
 
91.3 
8.7 
0 
 
43.5 
56.5 
 
39.1 
52.1 
4.3 
4,3 
   
 
Khawaja et al (2005) [14] in Pakistan researching benzodiazepines prescription in hospitalized 
patients, and they got result that among  the class of benzodiazepine, alprazolam was the second most 
commonly prescribed in the amount of 11.4% (44). On the prevalence, of the use of alprazolam in that study 
were 2,404% (5/208). This suggests that the prevalence of the use of alprazolam in RSMH still low compared 
with this study. Khawaja's research also found that the department of internal medicine is the departement 
where most patients took benzodiazepine (22.7% of 44 patients). The amount of use of alprazolam in internal 
medicine wards achieving 10% of the 208 patients. Prevalence of alprazolam administration in this study is 
still low when compared to research conducted by Vali et al (2012) [15] in Iran which found that the 
prevalence use of alprazolam is about 3.302% (7/212). 
Based on Table 3, it can be concluded that the group of 60-74 years was the most group who receive 
alprazolam (91.3%) which may be associated with an average life expectancy of people in South Sumatra. In 
the 75-90 year age group, there are 2 uses (8.7%), while at the very old age group (> 90 years) there is no use 
of alprazolam. This is consistent with research conducted by Nakao et al. (2009) [13] who find out that the 
65-74 year age group is the most group that received benzodiazepine (5355 patients). 
The calculation in Table 2 shows that the prevalence use of alprazolam in men group amounted to 
1.09% and the use in the female group is 1.798%. This is consistent with data from the WHO document On 
Substance Abuse Program (1996) [16] which states that the benzodiazepine prescriptions doubled in female 
patients than male patients. Similar data were presented by Reconnexion (2010), the group that experienced 
in the treatment of patients who get dependence to benzodiazepine in Victoria, that the class of 
benzodiazepine prescribed more in female patients than male [12]. 
 
 
Table 4. Alprazolam Indications 
 Total (n=23) Percentage (100%) 
Acute Myocardial Infarction, Unspecified 1 4.3 
Anaemia.Unspecified 1 4.3 
Asthma Unspecified 1 4.3 
Atherosclerotic Heart Disease (Cad) 2 8.7 
Chronic Obstructive Pulmonary Disease, 
Unspecified 
1 4.3 
Chronic Renal Failure,Unspecified 1 4.3 
Congestive Heart Failure (Chf) 1 4.3 
Diarrhoea & Gastroenteritis Of Presumed Infectious 
Origin 
2 8.7 
Dyspepsia 2 8.7 
Eseential (Primary) Hypertension 1 4.3 
Gastric Ulcer 1 4.3 
Gastritis, Unspecified 2 8.7 
Hypertensive Heart Disease Without (Congestive) 
Heart Failure 
1 4.3 
Non Insulin Dependent Diabetes Mellitus 1 4.3 
Other Diseases Of Digestive System => Melaena 1 4.3 
Other Gastritis 1 4.3 
Thyrotoxic Heart 
Disease(Thd)/Thyrotoxicosis/Unsspecified 
2 8.7 
Volume Depletion 1 4,3 
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Nakao et al [13] also found that female patients receive more benzodiazepine prescriptions than men 
in hospitalized patients in various departments (21.6%: 18.6%) and the percentage was increasing according 
to the age. This is similar to the results of Raoof et al. [17] research in Pakistan which found that more 
female patients get benzodiazepine than the male patients (37.8%: 25.3%) and users are more likely in older 
age. More number of prescribing in female patients may be due to the longer life expectancy of female than 
male [18]. 
In job variable, these results are also consistent with studies of Raoof et al [17] who found that the 
housewife is the most work groups which getting alprazolam in their life in Pakistan. That research was 
linking marital status as the psychosocial correlation with mental disorders. Khawaja et al [14] also found the 
same thing that housewife is the most group of inpatients who received benzodiazepines. 
Copernicus Knowledge System at UK in Isbister [19] provide data of alprazolam administration in 
general patients during June 1st, 2002 to September 30th 2002 period by a general practitioner. The data 
obtained shows that the indication of alprazolam prescription as follows: 310 cases of panic disorder (48%), 
194 cases of anxiety (30%), depression 18 cases (2.6%), anxiety / depression 26 cases (4%), insomnia 9 cases 
(1.6%), other 80 cases (12%), and no indication 194 cases. These data suggest that administration of 
alprazolam outside of the main / imprecise indication can reach 107 cases (9 cases of insomnia, depression 18 
cases, and other 80 cases). 
 
 
Table 5. The Proportion of Precise or Imprecise Indication 
 Total (n=23) Percentage (100%) 
Precise 
Imprecise 
0 
23 
0 
100 
 
 
Nakao et al  [13] in Japan conducted a study of hospitalized patients who received benzodiazepines 
in the hospital. The result obtained that the most patient who took benzodiazepine are patients with indication 
of chronic renal failure (31.3%), followed by heart failure (29.3%), acute myocardial infarction (28.9%), 
malignant neoplasm of the liver and intrahepatic bile ducts (28.0%), post-procedural disorders of the nervous 
system (28.0%), malignant neoplasm of the bronchus and lung (27.7%), noninsulin-dependent diabetes 
mellitus (25.0%), and malignant neoplasm of the bladder (22.2%). 
Meanwhile, Khawaja et al [14] found in his research that anxiety, insomnia, agitation, and 
depression are the reason that doctors use for prescribing alprazolam in hospitalized patients at Pakistan 
Teaching Hospital. Divac et al [20] also found that the class of benzodiazepines often administered to 
patients with cardiovascular problems and non-psychiatric diseases without the possibility of an anxiety 
disorder or other indications of benzodiazepine administration. 
The tendency of the alprazolam wrong prescription or included in the category of PIP also occur in 
research conducted by Tobat [21] who found eight geriatric patients who were treated at the department of 
internal medicine wards at DR. M. Djamil Hospital Padang got alprazolam outside of its truly indications. In 
that study the side effects of treatment occurred in two patients who undergo treatment with alprazolam. 
Tobat research using a prospective method for 3 months so that the side effect can be observed, in contrast to 
these studies that use descriptive method through analysis of medical records so that the side effects of 
treatment can not be found. 
The use of alprazolam as a form of inappropriate treatment is also found in the study of Akazawa et 
al. [22] in Japan. That study provided data of 10 class drugs which most often included in the Potenttialy 
Inappropriate medication in elderly patients and the benzodiazepine is the class number two of drugs 
commonly prescribed inappropriately (11.4% (756/6628)), with a short-acting class as much as 3.3% or 222 
patients. This suggests that there is a trend in the wrong prescription alprazolam in geriatric patients in 
various countries. 
However, further research by Akazawa et al. (2012) [23] in Japan through the recipe analysis also 
found that there is a trend of alprazolam improper prescribing in geriatric patients according to the criteria of 
beers in 2012. Akazawa et al found there were 24 (7.3%) patients taking alprazolam outside the main 
indication. Nakao et al [13] also stated that the benzodiazepine class of drugs is very often administered in 
the hospital without documentation of the indications. Elliot et al [24] also found that inappropriately 
benzodiazepine prescribing reach 16% of 36% prescription. 
Side effects of alprazolam in the treatment of hospitalized patients in this study could not be 
confirmed through medical record because the side effects were not written by a medical team in the care 
process. However, some common side effects in patients treated with alprazolam are seizures, loss of 
coordination (ataxia), and difficulty on concentrating, memory impairment/transient amnesia, hallucinations, 
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depersonalization, taste disorders, dystonia, irritability, anorexia, fatigue, sedation, musculoskeletal 
weakness, and incontinence. 
Beer's criteria in 2012 advocated a focus on the use of benzodiazepines, in this case the class of 
short-acting benzodiazepne; alprazolam. Beer recommend to avoid the use of benzodiazepines to treat 
patients with insomnia, agitation, and delirium because the elderly have increased sensitivity to 
benzodiazepines and increase the risk of cognitive impairment, delirium, falls, fractures, and accidents [25]. 
Alprazolam only indicated for patients with generalized anxiety disorders/GAD and panic attacks 
with or without agorapobia. However, in fact, alprazolam often prescribed to patients with complaints of 
difficulty sleeping (insomnia), especially by general practitioners [16]. However, in geriatric patients 
theirselves, specifically for GAD and panic attacks, alprazolam should be avoided because treatment with 
this drug will cause side effects such as falls, impaired memory and accumulation effects on the body. It is as 
formulated by the Western Australian Psychotropic Drugs Committee [26] and The College of Psychiatry of 
Ireland (2012) [27]  that suggest  to use selective serotonin reuptake inhibitors (SSRIs) in the case of anxiety 
disorders in the geriatric patient groups rather than alprazolam and avoid the use of all types of 
benzodiazepine. 
 
 
Table 6. Respondents’s Characteristics 
Variable Total  (n=23) Percentage (100%) 
Sex 
Male 
Female 
 
10 
13 
 
43.47  
56.53  
Age 
65-74 year 
75-90 year 
>90 year 
 
21 
2 
0 
 
91.31 
8.69  
0  
Dosage 
0,5 Mg 
1 Mg 
 
13 
10 
 
56.53 
43.47  
Frequency 
1 X 1 day (night) 
 
23 
 
100  
Duration of drug use 
1 day 
2 days 
3 days 
4 days 
5 days 
5 days (brought home) 
6 days 
9 days 
13 days 
15 days 
15 days (brought home)  
 
2 
4 
3 
1 
4 
3 
2 
1 
1 
1 
1 
 
8.69 
17.39 
13.04 
4.34 
17.39 
13.04 
8.69 
4.34 
4.34 
4.34 
4.34 
Patient’s complaint/ symptom 
Cough 
Nervous 
Chest pain 
Epigastric pain 
Joint pain 
Heartburn 
Headache 
Shortness of breath 
No indication 
Can’t sleep 
Not known 
 
1 
1 
2 
1 
1 
1 
1 
2 
2 
9 
2 
 
4.3 
4.3 
8.7 
4.3 
4.3 
4.3 
4.3 
8.7 
8.7 
39.1 
8.7 
 
 
Based on this recommendation, the actual administration of alprazolam in geriatric patients in 
internal medicine wards RSMH is improper when viewed from two sides, from the insomnia that is clearly 
wrong and from security aspect of the main indications (GAD and panic attacks). Nonetheless, some other 
guideline still allows the use of alprazolam in geriatric patients, but with some special attention, such as dose, 
duration of use, and interaction.  
There are several reasons why the improper administration of alprazolam may occur in the geriatric 
patient, such as the condition of the patients themselves and the factors that are derived from the physician 
(knowledge on the panel criteria, adherence to the guidline, and dependents for a pharmaceutical company) 
[28]. 
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Meanwhile, according to Moylan et al (2012) there are several reasons for the wrong prescription of 
alprazolam that are due to physician preference contrary to treatment guidelines, such as skepticism, lack of 
awareness and understanding of the principles of guidance, lack of expectations of treatment outcomes, and 
the existence of a pattern of practice habits (unable or unmotivated to change practice patterns), as well as the 
patient's own preferences (in this case the dependence). 
The clinicians desire to quickly relieve the patient's complaints (such as insomnia) and existing 
behavioral patterns [6], make alprazolam become the first choice for addressing patient complaints that cause 
the prevalence use of alprazolam in geriatric patients at RSMH Palembang was 1.408%. 
The limitation of this study is that the researchers are not able to directly assess the reasons why 
doctors give alprazolam to patients, so that researchers could only formulate it in the form of the main 
indications and patient complaints during the treatment process as presented in the table and the description 
above. 
Regardless, the prevalence use of alprazolam in geriatric patients in internal medicine wards RSMH 
is still low compared to similar studies that have been done. This is possibly because the use of alprazolam 
was more in outpatients than inpatients setting. In addition, the study shows that clobazam is more widely 
used than alprazolam in dealing with problems of patients during the treatment process.  
However, the persistences of the use of alprazolam are inclined towards Potenttialy Inappropriate 
Medication (PIM) according to criteria of Beer's shows that there were still a problem in the pattern of drug 
administration in geriatric patients and these things can be very dangerous because it can lead to the 
emergence of the problem such as dependence, tolerance, and the effects of drug withdrawal in the future. 
 
 
4. CONCLUSION 
We can conclude that the prevalence use of alprazolam is 1,408% with the 60-74 year age group is 
the largest group who received alprazolam (21 patients: 91.3%). More female patients getting alprazolam 
than male patients with a prevalence ratio of 1.798%: 1.09%. In job variable, most patients are housewives 
(52.1%). Most of alprazolam give to patients with complaints of atheroscerotic heart disease, diarrhoea and 
gastroenteritis of presumed infectious origin, dyspepsia, unspecified gastritis, and thyrotoxic heart disease 
(THD)/thyrotoxicosis/unsspecified. It can be concluded that all of alprazolam prescription was given outside 
a medical indication (no exact indication). While the side effects of the treatment could not be reported in this 
study due to side effects of treatment does not include the medical record. 
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